Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

BACKGROUND: Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Baden, Lindsey R., El Sahly, Hana M., Essink, Brandon, Kotloff, Karen, Frey, Sharon, Novak, Rick, Diemert, David, Spector, Stephen A., Rouphael, Nadine, Creech, C. Buddy, McGettigan, John, Khetan, Shishir, Segall, Nathan, Solis, Joel, Brosz, Adam, Fierro, Carlos, Schwartz, Howard, Neuzil, Kathleen, Corey, Larry, Gilbert, Peter, Janes, Holly, Follmann, Dean, Marovich, Mary, Mascola, John, Polakowski, Laura, Ledgerwood, Julie, Graham, Barney S., Bennett, Hamilton, Pajon, Rolando, Knightly, Conor, Leav, Brett, Deng, Weiping, Zhou, Honghong, Han, Shu, Ivarsson, Melanie, Miller, Jacqueline, Zaks, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787219/
https://www.ncbi.nlm.nih.gov/pubmed/33378609
http://dx.doi.org/10.1056/NEJMoa2035389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787219/
https://www.ncbi.nlm.nih.gov/pubmed/33378609
http://dx.doi.org/10.1056/NEJMoa2035389

Ejemplares similares